Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Pharmaceutical Commerce image

News from Pharmaceutical Commerce

See all of Pharmaceutical Commerce news coverage in one place. Discover how Pharmaceutical Commerce’s media bias informs their coverage and compare with thousands of other news outlets.

We’ve discovered 203 headlines written by Pharmaceutical Commerce during the past 3 months.

Pharmaceutical Commerce’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Is Pharmaceutical Commerce credible or reliable? Our Factuality score answers both of those questions. When it comes to Pharmaceutical Commerce, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about Pharmaceutical Commerce

Where is Pharmaceutical Commerce located?Pharmaceutical Commerce's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Pharmaceutical Commerce News

The Adoption of Artificial Intelligence in Clinical Care

Artificial Intelligence · Mannheim

The Adoption of Artificial Intelligence in Clinical Care

100% Center coverage: 3 sources

Integrating AI with electronic medical records may revolutionize clinical practice.See the Story

Generic Drugmaker Hikma Pledges $1bn in US Investment

Innovation · United States

Generic Drugmaker Hikma Pledges $1bn in US Investment

100% Center coverage: 2 sources

With tariffs looming, Indian drugmaker Hikma has said it will spend $1bn to expand its manufacturing and R&D operations in the US by 2030.See the Story

Accelerating Decision-Making Processes During Market Volatility

Pharma · Hesse

Accelerating Decision-Making Processes During Market Volatility

100% Center coverage: 1 sources

Nick Petschek, Kotter International discusses how market turbulence is taking a toll on the pharmaceutical industry.See the Story

How Funding Cuts Are Undermining Patient Recruitment In Clinical Trials - Data Intelligence

In a recent video interview with Applied Clinical Trials, Kyle McAllister, co-founder, CEO, Trially, discussed the impact of funding cuts on underrepresented populations in medical research, emphasizing the importance of diversity-focused research. He highlighted the challenges created by budget cuts, particularly in patient recruitment and retention, due to reduced support staff. McAllister noted that artificial intelligence (AI) and new techno…Johnson & Johnson · United States See the Story

The Evolution of the CGT Launch and Distribution Model

In the final part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, predicts how he anticipates the model growing over the next three to five years, especially as global demand and regulatory complexities increase.Read Article

Pharma Pulse 7/2/25: The Impact of FDA’s Ban on Compounded GLP-1s; How Sites and Sponsors Are Adapting to Clinical Trial Budget Cuts

Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.United States · United States Read Article

How Patient Advocacy Is Guiding Rare Disease Drug Development

Bruce Leuchter, CEO, Neurvati, discusses the vital role of public participation in healthcare policy, highlighting how patient and caregiver insights shape drug development, regulatory decisions, and payer considerations in rare diseases.Read Article

Medicaid’s Role in the CGT Sector

State Medicaid leaders create a plan to ensure safety, affordability, and equitable access for children and families living with rare diseases.United States · United States Read Article

Real-World Evidence Market To Surpass USD 5.27 bilion 2032, to Grow at a CAGR of 14.3 % From 2025 To 2032

Open the article to view the coverage from kalkinemedia.comArtificial Intelligence See the Story

Pharma Pulse 6/30/25: Preparing for Federal Regulations; Funding Cuts Threaten Diversity in Clinical Research

Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.Regulation · United States Read Article

Peer Exchange: Developing a Manufacturing Contingency Plan (Episode 2)

In the second part of this roundtable discussion, a panel of key opinion leaders dive into the key risk factors impacting the pharma manufacturing space, and how the industry should aim to address them.Read Article

Breaking News Topics Related to Pharmaceutical Commerce